Aura Biosciences (AURA) Free Cash Flow Growth (3y) (2023 - 2026)
Aura Biosciences (AURA) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Aura Biosciences | 477.53 Mn | 392.74 Mn | - | -21.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.92% |
| Dec 31, 2025 | -5.68% |
| Sep 30, 2025 | -22.18% |
| Jun 30, 2025 | -25.03% |
| Mar 31, 2025 | -14.62% |
| Dec 31, 2024 | -32.02% |
| Sep 30, 2024 | -17.04% |
| Jun 30, 2024 | -30.58% |
| Mar 31, 2024 | -67.73% |
| Dec 31, 2023 | -64.21% |